Prot #OT-15-001: A Phase 3, Randomized, Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine with Lomustine Compared to Lomustine Alone in Patients with Anaplastic Astrocytoma That Progress/Recur After Irradiation and Adjuvant Temozolomide

Project: Research project

Project Details

StatusActive
Effective start/end date1/5/17 → 1/5/26

Funding

  • PRA Health Sciences ((OE) Prot #OT-15-001 // (OE) Prot #OT-15-001)
  • Orbus Therapeutics, Inc. ((OE) Prot #OT-15-001 // (OE) Prot #OT-15-001)